New asthma and COPD drug enters first human safety tests
NCT ID NCT07116889
First seen Nov 05, 2025 · Last updated May 23, 2026 · Updated 23 times
Summary
This early-stage study tests a new medicine called GB-0895 in adults with mild-to-moderate asthma or COPD. The main goal is to check if the drug is safe and how the body handles it. About 156 participants will receive either the drug or a placebo. This research is a first step toward possibly easing breathing symptoms in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Alcanza
DeLand, Florida, 32720, United States
-
Charite Research Organization GmbH
Berlin, Germany
-
DM Clinical Research
Tomball, Texas, 77375, United States
-
Fraunhofer Institut fur Toxikologie and Experimentelle Medizin (ITEM)
Hanover, Germany
-
Hammersmith Medicines Research
London, United Kingdom
-
IKF Pneumologie
Frankfurt, Germany
-
Medicines Evaluation Unit (MEU)
Manchester, United Kingdom
-
Miami Research Institute of South Florida
Miami, Florida, 33173, United States
-
Nucleus Network
Saint Paul, Minnesota, 55114, United States
-
Omega Research
Orlando, Florida, 32808, United States
-
Queen Anne Street Medical Center
London, United Kingdom
-
Simbec-Orion Clinical Development
Merthyr Tydfil, United Kingdom
-
Southeastern Research Center
Winston-Salem, North Carolina, 27103, United States
Conditions
Explore the condition pages connected to this study.